Current Report Filing (8-k)
May 26 2016 - 4:08PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
May 26, 2016
Date of report (date of earliest event
reported)
MusclePharm Corporation
(Exact name of registrant as specified
in its charter)
|
|
|
|
|
Nevada
|
|
000-53166
|
|
77-0664193
|
(State or other jurisdictions of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification Nos.)
|
4721 Ironton Street, Building A
Denver, Colorado 80239
(Address of principal
executive offices) (Zip Code)
(303) 396-6100
(Registrant’s telephone number,
including area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrants under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
On May 26, 2016, the Company issued a press release announcing
an update to its restructuring plan.
A copy of the press release is attached hereto as Exhibit 99.1
|
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits:
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release of
MusclePharm Corporation
, dated May 26, 2016.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
MUSCLEPHARM CORPORATION
|
|
|
|
|
By:
|
/s/ John Price
|
|
|
|
Name: John Price
Title: Chief Financial Officer
|
Date: May 26, 2016
EXHIBIT INDEX
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release of
MusclePharm Corporation
, dated May 26, 2016.
|
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Muscle Pharm (CE) (USOTC:MSLP)
Historical Stock Chart
From Apr 2023 to Apr 2024